Sexual Dysfunction in Women With Multiple Sclerosis (MS)
- Conditions
- Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingFatigue in Multiple SclerosisSexual DisfunctionCognitive DysfunctionDepressionAnxietyOveractive BladderFatigue
- Registration Number
- NCT07193823
- Lead Sponsor
- Ege University
- Brief Summary
Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.
For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 140
- Female patients aged 25-50 years
- Literate and able to comprehend written and spoken instructions
- Diagnosed with relapsing-remitting form of multiple sclerosis
- Having a continuous/regular sexual partner
- Expanded Disability Status Scale (EDSS) score ≤ 5
- At least 3 months since the last relapse
- Sexually active within the past 3 months
- Spasticity level < grade 2 according to the Modified Ashworth Scale
- Pregnancy
- Illiteracy or inability to understand spoken or written instructions
- Absence of a continuous/regular sexual partner
- Expanded Disability Status Scale (EDSS) score > 5
- Not sexually active within the past 3 months
- Spasticity level ≥ grade 2 according to the Modified Ashworth Scale
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of sexual dysfunction in female patients with multiple sclerosis At enrollment (Baseline, cross-sectional assessment)
- Secondary Outcome Measures
Name Time Method Association between sexual dysfunction and cognitive dysfunction, fatigue, depression, anxiety, and overactive bladder symptoms At enrollment (Baseline, cross-sectional assessment)
Trial Locations
- Locations (1)
Ege University Faculty of Medicine, Department of Neurology
Izmir, Bornova, Turkey (Türkiye)
Ege University Faculty of Medicine, Department of NeurologyIzmir, Bornova, Turkey (Türkiye)